Q: Hello, Can you find any news to explain 6% decline today. Analyst downgrade?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: What is your assessment ? Thank you
Q: I just noticed a press release from SANOFI (on Bloomberg) discussing the same treatments discussed in latest PLI press release. Does this suggest a chance for a partnership opportunity or just a coincedence?
Q: Looking at buying zbh for a Long term time horizon.. Any feedback is appreciated.
John M
John M
Q: Cardinal Health may I have your thoughts on this company
Q: Hi, I have the above stock in non registered account. As of today I lost $4000 US , bought it at 102 and now $67 $ US. What do you recommend? Sell it and claim loss or wait till it recover or add more to it. I added to it when it became $70 US. But it seems it is not doing well. I appreciate your ultimate decision on it or if there is any US solid stocks that you recommend. Thanks
Q: Nobilis's stock price is under increasing pressure since they released their 4th quarter earnings. Although the earnings were a disappointed, I am puzzled as to why the stock continues to sell off. Anything you can tell me would be great.
Q: Are there any ETFs that are the equivalent to ZUH but are traded in American dollars?
Q: Mr. Hodson, why do your feel so confident of the future for GUD ?
Q: What is your opinion ? Thank you
Q: Hi,
Is their any price at which either CXR or VRX would interest you or do you view both of them as uninvestable?
Regards,
Robert
Is their any price at which either CXR or VRX would interest you or do you view both of them as uninvestable?
Regards,
Robert
Q: 2 questions on GUD:
* Recent report states " GUD also invests in funds, which have substantial assets under management in the healthcare sector..." What type of funds, private equity or mutual, and how major is this part of their business?
* Your models have 3 and 6% positions in this name, my weight is 2.5% and I'm wondering what is a suitable number, though I would be comfortable up to 5%. I am retired and it is presently my only health care stock.
Thanks, J.
* Recent report states " GUD also invests in funds, which have substantial assets under management in the healthcare sector..." What type of funds, private equity or mutual, and how major is this part of their business?
* Your models have 3 and 6% positions in this name, my weight is 2.5% and I'm wondering what is a suitable number, though I would be comfortable up to 5%. I am retired and it is presently my only health care stock.
Thanks, J.
Q: Prometic announced a small ($9.5 million) purchase order from an existing client last Friday, and they seem primed for several growth opportunities/catalysts in 2017. Yet the share price keeps dropping.
Would you be on board with an initial purchase at this time? Or wait for more good news?
Thank you.
Would you be on board with an initial purchase at this time? Or wait for more good news?
Thank you.
Q: CRH has lots of momentum currently. I am starting to get concerned about P/E ratios. What is the P/E to growth ratio, and please give some comments on the company\s ability to grow earning to meet this ratio.
cheers
cheers
Q: In the last question related to CRH, you indicated that it had a forward PE Ratio of over 40X, and a P/BV ratio of 14X.
That sounds very expensive, even if it is a high growth stock. How is this any different than some of the marijuana stocks you have indicated we should avoid due to extended valuations?
I guess my question is - how do you know when a stock is too expensive? Is there a metric one can use that says x% revenue growth can be priced as high as 'y' P/E or 'z' P/BV?
That sounds very expensive, even if it is a high growth stock. How is this any different than some of the marijuana stocks you have indicated we should avoid due to extended valuations?
I guess my question is - how do you know when a stock is too expensive? Is there a metric one can use that says x% revenue growth can be priced as high as 'y' P/E or 'z' P/BV?
Q: hi, what do you think of HHL at this price? we are retiring next year and looking for income , do you like HHL or is there something you prefer thx Jack.
Q: Could you provide your views and long term prospects for this company? Does it give any dividends?
Thanks
Thanks
Q: Internal discussions at my end!! What is the current Price to Book (I calculate - just over 10. Also I figure the P/E ratio about 60. Do you agree? Thank you.
Q: After Aup announced successful clinical trail its price reached a high of US$10.54 on 3/13.Then on 3/14 it announced financing of 22.3m shares @ us $6.75.Since then it has declined to current level of US$6.92.Trades in USA as AUPH. Please advise if it is buyable here.Appreciate u normal great services & views.
Q: Do you consider Medicure Inc. a Buy at these levels. Thanks.